Skip to main content

Table 1 Clinicopathological information.

From: Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses

Tumor

Tumor ID

Dukes' stage a

TP53 mutation status b

Sex c

Age d

primary carcinomas

923P

C

wildtype

M

85

 

974P

B

ex8, c273, CGT→CAT, Arg→His

M

73

 

980P

C

wildtype

F

75

 

984P

C

wildtype

F

88

 

988P

B

wildtype

F

66

 

1029P

C

wildtype

M

83

 

1069P

B

wildtype

M

74

 

887P

B

wildtype

F

82

 

927P

B

ex6, c190, CCT→CTT, Pro→Leu

F

73

 

953P

B

ex6, 5 bp insertion; c216–217: GTG GTG to GTGgtggtGTG

M

68

 

976P

B

wildtype

M

58

 

1027P

B

ex7, c241–242, TCCTGC→TTCCGC, Ser-Cys→Phe-Arg

M

79

 

868P

B

wildtype

M

64

 

904P

B

ex8, c272, CTG→ATG, Val→Met

M

78

 

912P

B

wildtype

F

66

 

941P

B

ex8, c282, CGG→TGG, Arg→Trp

M

78

 

1276P

B

wildtype

M

79

 

1296P

B

ex7, c244, GGC→GTC, Gly→Val

M

76

liver metastases

136L

D

ex5, c132, AAG→AGG, Lys→Arg

M

68

 

81L

D

wildtype

M

74

 

2L

C

wildtype

M

75

 

76L

D

ex7, c241, TCC→TC, 1 bp deletion

M

55

carcinomatoses

98C

D

wildtype

M

72

 

1C

D

wildtype

F

62

 

17C

C

ex5, c175, CGC→CAC, Arg→His

F

67

 

64C

D

wildtype

M

40

  1. aDukes' stage of the primary tumors, and the primary tumor of liver metastases and carcinomatoses. bex, exon; c, codon; bp, base pair. cM, male; F, female. dAge at diagnosis.